AAAAAA
Results: 1-25/43
Authors:
EASTHAM JA
MAY RA
WHATLEY T
CROW A
VENABLE DD
SARTOR O
Citation: Ja. Eastham et al., CLINICAL CHARACTERISTICS AND BIOPSY SPECIMEN FEATURES IN AFRICAN-AMERICAN AND WHITE MEN WITHOUT PROSTATE-CANCER, Journal of the National Cancer Institute, 90(10), 1998, pp. 756-760
Authors:
FEUER JA
LUSH RM
VENZON D
DURAY P
TOMPKINS A
SARTOR O
FIGG WD
Citation: Ja. Feuer et al., ELEVATED CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Journal of investigative medicine, 46(2), 1998, pp. 66-72
Authors:
DAWSON N
FIGG WD
BRAWLEY OW
BERGAN R
COOPER MR
SENDEROWICZ A
HEADLEE D
STEINBERG SM
SUTHERLAND M
PATRONAS N
SAUSVILLE E
LINEHAN WM
REED E
SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
Authors:
DAWSON N
FIGG WD
BRAWLEY OW
BERGAN R
COOPER MR
SENDEROWICZ A
HEADLEE D
STEINBERG SM
SUTHERLAND M
PATRONAS N
SAUSVILLE E
LINEHAN WM
REED E
SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
Authors:
HORTI J
FIGG WD
WEINBERGER B
KOHLER D
SARTOR O
Citation: J. Horti et al., A PHASE-II STUDY OF BROMOCRIPTINE IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Oncology Reports, 5(4), 1998, pp. 893-896
Authors:
BOILEAU T
FERRUZZI M
SARTOR O
SCHWARTZ S
ERDMAN J
CLINTON S
Citation: T. Boileau et al., LYCOPENE ISOMERS AND CAROTENOID PROFILES IN AFRICAN-AMERICAN (AA) ANDCAUCASIAN (C) MEN, The FASEB journal, 12(5), 1998, pp. 4957-4957
Authors:
BENNETT CL
FERREIRA MR
DAVIS TC
KAPLAN J
WEINBERGER M
KUZEL T
SEDAY MA
SARTOR O
Citation: Cl. Bennett et al., RELATION BETWEEN LITERACY, RACE, AND STAGE OF PRESENTATION AMONG LOW-INCOME PATIENTS WITH PROSTATE-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 3101-3104
Authors:
SARTOR O
WEINBERGER M
MOORE A
LI AL
FIGG WD
Citation: O. Sartor et al., EFFECT OF PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Urology, 52(2), 1998, pp. 252-256
Authors:
SARTOR O
EASTHAM JA
VENABLE DD
WILLIAMS P
Citation: O. Sartor et al., RACIAL VARIATION IN PSA IN A WELL-DEFINED COHORT OF MEN WITHOUT KNOWNPROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 894-894
Authors:
VANBINGHAM W
EASTHAM JA
SARTOR O
FIGG WD
Citation: W. Vanbingham et al., LACK OF GLEASONS SUM EFFECT ON SURVIVAL IN PATIENTS WITH STAGE D2 PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 1156-1156
Authors:
EASTHAM JA
SARTOR O
Citation: Ja. Eastham et O. Sartor, NILUTAMIDE RESPONSE AFTER FLUTAMIDE FAILURE IN POSTORCHIECTOMY PROGRESSIVE PROSTATE-CANCER, The Journal of urology, 159(3), 1998, pp. 990-990
Authors:
HENDERSON RJ
EASTHAM JA
CULKIN DJ
KATTAN MW
WHATLEY T
MATA J
VENABLE D
SARTOR O
Citation: Rj. Henderson et al., PROSTATE-SPECIFIC ANTIGEN (PSA) AND PSA DENSITY - RACIAL-DIFFERENCES IN MEN WITHOUT PROSTATE-CANCER, Journal of the National Cancer Institute, 89(2), 1997, pp. 134-138
Authors:
DAWSON NA
FIGG WD
COOPER MR
SARTOR O
BERGAN RC
SENDEROWICZ AM
STEINBERG SM
TOMPKINS A
WEINBERGER B
SAUSVILLE EA
REED E
MYERS CE
Citation: Na. Dawson et al., PHASE-II TRIAL OF SURAMIN, LEUPROLIDE, AND FLUTAMIDE IN PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1470-1477
Authors:
SARTOR O
ZHENG Q
Citation: O. Sartor et Q. Zheng, DETERMINATION OF CAG REPEAT LENGTH IN THE ANDROGEN-RECEPTOR GENE USING FROZEN SERUM, Urology, 49(2), 1997, pp. 301-304
Authors:
WILLIAMS PB
EASTHAM JA
CULKIN DJ
MATA JA
VENABLE DD
SARTOR O
Citation: Pb. Williams et al., INFLUENCE OF HEPATIC-FUNCTION ON SERUM LEVELS OF PROSTATE-SPECIFIC ANTIGEN, The Journal of urology, 158(5), 1997, pp. 1867-1869
Authors:
FIGG WD
KROOG G
DURAY P
WALTHER MM
PATRONAS N
SARTOR O
REED E
Citation: Wd. Figg et al., FLUTAMIDE WITHDRAWAL PLUS HYDROCORTISONE RESULTED IN CLINICAL COMPLETE RESPONSE IN A PATIENT WITH PROSTATE CARCINOMA, Cancer, 79(10), 1997, pp. 1964-1968
Authors:
LUSH RM
FIGG WD
PLUDA JM
BITTON R
HEADLEE D
KOHLER D
REED E
SARTOR O
COOPER MR
Citation: Rm. Lush et al., A PHASE-I STUDY OF PENTOSAN POLYSULFATE SODIUM IN PATIENTS WITH ADVANCED MALIGNANCIES, Annals of oncology, 7(9), 1996, pp. 939-944
Authors:
FIGG WD
AMMERMAN K
PATRONAS N
STEINBERG SM
WALLS RG
DAWSON N
REED E
SARTOR O
Citation: Wd. Figg et al., LACK OF CORRELATION BETWEEN PROSTATE-SPECIFIC ANTIGEN AND THE PRESENCE OF MEASURABLE SOFT-TISSUE METASTASES IN HORMONE-REFRACTORY PROSTATE-CANCER, Cancer investigation, 14(6), 1996, pp. 513-517
Authors:
BOWDEN CJ
FIGG WD
DAWSON NA
SARTOR O
BITTON RJ
WEINBERGER MS
HEADLEE D
REED E
MYERS CE
COOPER MR
Citation: Cj. Bowden et al., A PHASE I II STUDY OF CONTINUOUS-INFUSION SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - TOXICITY AND RESPONSE/, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 1-8
Authors:
MIDDLEMAN MN
LUSH RM
SARTOR O
REED E
FIGG WD
Citation: Mn. Middleman et al., TREATMENT APPROACHES FOR METASTATIC CANCER OF THE PROSTATE BASED ON RECENT MOLECULAR EVIDENCE, Cancer treatment reviews, 22(2), 1996, pp. 105-118
Authors:
FIGG WD
DAWSON N
MIDDLEMAN MN
BRAWLEY O
LUSH RM
SENDEROWICZ A
STEINBERG SH
TOMPKINS A
REED E
SARTOR O
Citation: Wd. Figg et al., FLUTAMIDE WITHDRAWAL AND CONCOMITANT INITIATION OF AMINOGLUTETHIMIDE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Acta oncologica, 35(6), 1996, pp. 763-765
Authors:
SARTOR O
FIGG WD
Citation: O. Sartor et Wd. Figg, MIFEPRISTONE - ANTINEOPLASTIC STUDIES, Clinical obstetrics and gynecology, 39(2), 1996, pp. 498-505
Authors:
SARTOR O
CUTLER GB
Citation: O. Sartor et Gb. Cutler, MIFEPRISTONE - TREATMENT OF CUSHINGS-SYNDROME, Clinical obstetrics and gynecology, 39(2), 1996, pp. 506-510
Authors:
FIGG WD
MIDDLEMAN MN
SARTOR O
Citation: Wd. Figg et al., THERAPEUTIC OPTIONS IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - REPLY, The American journal of medicine, 100(2), 1996, pp. 243-244
Authors:
SARTOR O
Citation: O. Sartor, PROSTATE-SPECIFIC ANTIGEN CHANGES BEFORE AND AFTER ADMINISTRATION OF AN ANGIOGENESIS INHIBITOR (TNP-470), Oncology Reports, 2(6), 1995, pp. 1101-1102